GlassScriptPhysician profile
Craig J Baker
NPI 1922020833
$58,064.87
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $2,125 · 2022: $10K · 2023: $6,573 · 2024: $16K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $4,347 · Food and Beverage: $3,527 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,750.00 |
| Travel and Lodging | $4,346.65 |
| Food and Beverage | $3,526.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $43,784.98 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Baxter Healthcare | $9,178.16 | 2019 | |
| Abbott Laboratories | $4,104.00 | 2019-2025 | Epic |
| Atricure, INC. | $473.15 | 2022-2025 | Synergy Ablation System |
| Artivion, INC. | $216.82 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, Amds-Ascyrus Medical |
| Medtronic, INC. | $88.88 | 2023-2024 | Penditure, Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $76.31 | 2024 | Imfinzi |
| Medtronic Vascular, INC. | $62.64 | 2019 | |
| Abiomed | $58.54 | 2023 | Impella |
| Genzyme Corporation | $21.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.